LinkedIn post ESRR2024

📢 Important update on EU #GMP Annex 1 at #ESRR2024!

The revised EU GMP Annex 1, effective since August 2023, has undergone a significant expansion, growing from 16 to a comprehensive 58 pages! 👉 Join the round table on GMP and Legislation featuring the expertise of Lars Perk — one of the three distinguished experts leading the discussion. He proposes to explore the new requirements, detailed insights, and an intensified focus on risk management and contamination control strategy.

📚 He studied Chemistry at the University of Wageningen and obtained his PhD at the VUmc in Amsterdam. In 2008, he joined the BV Cyclotron of the VU in Amsterdam as R&D project manager. In this position, he was responsible for the development of new (mainly 18F) radiopharmaceuticals. He was also closely involved in the realization of a new manufacturing unit for radiopharmaceuticals for the VUmc. Since August 2013, he is Operational Manager at Radboud Translational Medicine (RTM). Since December 2016, he is Managing Director. He is also the coordinating radiation protection expert and Qualified Person at RTM.

🔎Don’t miss the chance to participate and gain insights onto the impact of the revised Annex 1, attend the round table for an in-depth discussion: https://lnkd.in/d-QUaPMX

#Pharmaceuticals #Radiopharmaceuticals #RiskManagment #Innovation